肝门部胆管癌术前胆道引流的现状和研究进展

Current Status and Research Progress of Preoperative Biliary Drainage for Hilar Cholangiocarcinoma

肝门部胆管癌患者常采取手术根治切除治疗,术前胆道引流(PBD)通过降低患者体内的血清总胆红素,提升肝功能,改善梗阻性黄疸,能够达到改善预后,降低并发症发生概率、手术病死率的目的。自PBD出现以来,因其应用的有效性,已成为患者术前管理的重要内容,但临床对其应用的指征、首选应用方式、种植转移等仍存在争议。本文就肝门部胆管癌术前应用PBD的现状、进展进行综述。

Patients with hilar cholangiocarcinoma often undergo radical resection.Preoperative biliary drainage(PBD) can improve prognosis,reduce the incidence of complications and operative mortality by reducing serum total bilirubin,improving liver function and improving obstructive jaundice.Since the emergence of PBD,because of its effectiveness,it has become an important part of preoperative management of patients.However,there are still controversies in clinical indications,preferred application methods,implant transfer and so on.This article reviews the current status and progress of preoperative application of PBD in hilar cholangiocarcinoma.